HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yolanda Barbachano Selected Research

Cisplatin (Platino)

5/2010Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yolanda Barbachano Research Topics

Disease

4Neoplasms (Cancer)
01/2018 - 06/2009
3Colorectal Neoplasms (Colorectal Cancer)
03/2013 - 04/2009
3Rectal Neoplasms (Rectal Cancer)
05/2012 - 04/2009
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2019
2Neoplasm Metastasis (Metastasis)
03/2013 - 08/2012
2Disease Progression
08/2012 - 08/2011
2Prostatic Neoplasms (Prostate Cancer)
12/2009 - 06/2007
1Infections
01/2019
1Acute Promyelocytic Leukemia
01/2019
1Hemorrhage
01/2019
1Adenocarcinoma
05/2013
1Squamous Cell Neoplasms (Squamous Cell Cancer)
02/2012
1Hypopharyngeal Neoplasms
02/2012
1Thyroid Neoplasms (Thyroid Cancer)
08/2011
1Testicular Neoplasms (Testicular Cancer)
05/2010
1Peripheral Nervous System Diseases (PNS Diseases)
05/2010
1Raynaud Disease (Raynaud's Disease)
05/2010
1Anaplastic Thyroid Carcinoma
06/2009
1Lung Neoplasms (Lung Cancer)
05/2009
1Squamous Cell Carcinoma of Head and Neck
05/2009
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2008
1Spinal Cord Compression
12/2007
1Neurologic Manifestations (Neurological Manifestations)
12/2007
1Back Pain (Backache)
12/2007

Drug/Important Bio-Agent (IBA)

3Capecitabine (Xeloda)FDA Link
05/2013 - 03/2010
3Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2013 - 03/2010
2Daunorubicin (Cerubidine)FDA LinkGeneric
01/2020 - 01/2019
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2020 - 01/2019
1Liposomes (Liposome)IBA
01/2020
1Gemtuzumab (Mylotarg)FDA Link
01/2019
1Pharmaceutical PreparationsIBA
01/2018
1Panitumumab (Vectibix)FDA Link
05/2013
1Epirubicin (Ellence)FDA LinkGeneric
05/2013
1Bevacizumab (Avastin)FDA Link
03/2013
1Cetuximab (Erbitux)FDA Link
05/2012
1Sorafenib (BAY 43-9006)FDA Link
08/2011
1Carboplatin (JM8)FDA LinkGeneric
05/2010
1Cisplatin (Platino)FDA LinkGeneric
05/2010
1Biological ProductsIBA
12/2009
1Biomarkers (Surrogate Marker)IBA
12/2009
1Rad51 RecombinaseIBA
12/2009
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2009
1ErbB Receptors (EGF Receptor)IBA
05/2009
1Fluorouracil (Carac)FDA LinkGeneric
04/2009
1Leucovorin (Folinic Acid)FDA Link
04/2009
1Gefitinib (Iressa)FDA Link
02/2008
1Docetaxel (Taxotere)FDA Link
02/2008
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2008
1Follicle Stimulating Hormone (Follitropin)FDA Link
06/2007
1Testosterone (Sustanon)FDA Link
06/2007
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
06/2007
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
06/2007

Therapy/Procedure

5Drug Therapy (Chemotherapy)
05/2013 - 05/2010
4Therapeutics
01/2020 - 03/2010
4Radiotherapy
05/2012 - 06/2007
2Neoadjuvant Therapy
08/2012 - 05/2012
2Chemoradiotherapy
05/2012 - 03/2010
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2012
1Induction Chemotherapy
02/2012
1Combination Drug Therapy (Combination Chemotherapy)
03/2010
1Adjuvant Chemotherapy
04/2009
1Aftercare (After-Treatment)
06/2007